# Valproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening

> **NCT00870688** · — · COMPLETED · sponsor: **Desitin Arzneimittel GmbH** · enrollment: 82 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** sodium valproate

## Key facts

- **NCT ID:** NCT00870688
- **Lead sponsor:** Desitin Arzneimittel GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2009-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870688, "Valproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00870688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*